100 related articles for article (PubMed ID: 22212564)
21. Molecule of the month. Telaprevir.
Drug News Perspect; 2010 Jun; 23(5):329. PubMed ID: 20603656
[No Abstract] [Full Text] [Related]
22. The end of hepatitis C.
Sussman NL; Remien CH; Kanwal F
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):533-6. PubMed ID: 24480676
[No Abstract] [Full Text] [Related]
23. Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061.
Herrmann E; Zeuzem S; Sarrazin C; Hinrichsen H; Benhamou Y; Manns MP; Reiser M; Reesink H; Calleja JL; Forns X; Steinmann GG; Nehmiz G
Antivir Ther; 2006; 11(3):371-6. PubMed ID: 16759054
[TBL] [Abstract][Full Text] [Related]
24. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
25. Future treatment of chronic hepatitis C.
Keeffe EB
Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
[TBL] [Abstract][Full Text] [Related]
26. Telaprevir.
Prescrire Int; 2012 Apr; 21(126):93-6. PubMed ID: 22515133
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
Serfaty L
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
[No Abstract] [Full Text] [Related]
28. Virology: fresh assault on hepatitis C.
Rice CM
Nature; 2003 Nov; 426(6963):129-31. PubMed ID: 14578912
[No Abstract] [Full Text] [Related]
29. Future directions in therapy for chronic hepatitis C.
Jensen DM; Ascione A
Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
[TBL] [Abstract][Full Text] [Related]
30. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
31. The conundrum of relapse in STAT-C therapy: does HCV play the Red Queen or Rip Van Winkle?
Ralston R; Jacobson I; Scull M
Semin Liver Dis; 2011 Nov; 31(4):410-9. PubMed ID: 22189980
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the evidence from clinical trials in chronic hepatitis C.
Brown RS
J Viral Hepat; 2006 May; 13 Suppl 1():15-25. PubMed ID: 16630043
[TBL] [Abstract][Full Text] [Related]
33. Boceprevir.
Prescrire Int; 2012 Apr; 21(126):89-92. PubMed ID: 22515132
[TBL] [Abstract][Full Text] [Related]
34. Recent developments in target identification against hepatitis C virus.
Brass V; Blum HE; Moradpour D
Expert Opin Ther Targets; 2004 Aug; 8(4):295-307. PubMed ID: 15268625
[TBL] [Abstract][Full Text] [Related]
35. [The 6th International Hepatology Congress "White Nights of Hepatology", Saint-Petersburg, June 2014].
Golovanova EV
Eksp Klin Gastroenterol; 2014; (7):98-100. PubMed ID: 25842413
[No Abstract] [Full Text] [Related]
36. Viral hepatitis: impressive advances but still a long way to eradication of the disease.
Marcellin P; Asselah T
Liver Int; 2014 Feb; 34 Suppl 1():1-3. PubMed ID: 24373070
[No Abstract] [Full Text] [Related]
37. A world without hepatitis C.
Ryder S; Dillon J
Health Serv J; 2014 May; 124(6397):21-3. PubMed ID: 25033511
[No Abstract] [Full Text] [Related]
38. What price for a cure?
Taylor LE
R I Med J (2013); 2014 Jul; 97(7):16-8. PubMed ID: 25184174
[No Abstract] [Full Text] [Related]
39. Preface. Hepatitis C infection.
Janssen H; Craxi A
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):369. PubMed ID: 23199496
[No Abstract] [Full Text] [Related]
40. Editorial: Hepatitis C virus eradication improves skeletal muscle mass.
Tian CJL; Ngu JH
Aliment Pharmacol Ther; 2024 Jun; 59(11):1446-1447. PubMed ID: 38711374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
